Palleon Pharmaceuticals Recognized as a Fierce Biotech “Fierce 15” Company for 2023

Palleon named as one of Fierce Biotech

Apnimed LinkedIn

Palleon Pharmaceuticals on LinkedIn: #fierce15

E-602: Drug Targets, Indications, Patents - Synapse

Alan Colowick posted on LinkedIn

Fierce15 - Twitter Hashtag

TAG: Preclinical News

Palleon Pharmaceuticals on LinkedIn: #fierce15

Chris Jenkins on LinkedIn: Introducing Fierce Biotech's 2023 Fierce 15

HiFiBiO Therapeutics

About Us – Palleon Pharmaceuticals

Pushpa Jayaraman, Ph.D. posted on LinkedIn

michelle larned on LinkedIn: Introducing Fierce Biotech's 2023 Fierce 15

News – Palleon Pharmaceuticals

Palleon Pharmaceuticals on LinkedIn: #fierce15

Alan Colowick on LinkedIn: Excited about Zentalis Pharmaceuticals updated monotherapy data